| Arsenic trioxide — An old drug rediscovered | 2010/07/01 | English | 198 |
| Molecular biomarkers in acute myeloid leukemia | 2017/01/01 | English | 177 |
| The molecular basis of hereditary red cell membrane disorders | 2007/01/01 | English | 176 |
| G6PD deficiency: the genotype-phenotype association | 2007/09/01 | English | 173 |
| RhD haemolytic disease of the fetus and the newborn | 2000/03/01 | English | 165 |
| Vitamin K deficiency bleeding (VKDB) in early infancy | 2009/03/01 | English | 161 |
| Blood-derived biomaterials and platelet growth factors in regenerative medicine | 2013/03/01 | English | 160 |
| Chimeric antigen receptor T cell therapy: 25years in the making | 2016/05/01 | English | 156 |
| Pathogenesis and treatment of anaemia of chronic disease | 2002/06/01 | English | 155 |
| Interplay between platelets and coagulation | 2021/03/01 | English | 155 |
| Anemia in the elderly: Current understanding and emerging concepts | 2006/07/01 | English | 154 |
| Apoptosis in the anucleate platelet | 2012/03/01 | English | 151 |
| The fundamental role of epigenetics in hematopoietic malignancies | 2006/01/01 | English | 151 |
| Reducing the risk of infection from plasma products: specific preventative strategies | 2000/06/01 | English | 149 |
| New insights into iron deficiency and iron deficiency anemia | 2017/07/01 | English | 149 |
| Immune hemolytic anemia associated with drug therapy | 2010/07/01 | English | 148 |
| Old and new oral anticoagulants: Food, herbal medicines and drug interactions | 2017/07/01 | English | 147 |
| Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine | 2014/07/01 | English | 141 |
| Managing critically Ill hematology patients: Time to think differently | 2015/11/01 | English | 140 |
| Therapeutic potential of embryonic stem cells | 2005/11/01 | English | 136 |
| Current concepts: large granular lymphocyte leukemia | 1999/12/01 | English | 131 |
| High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma | 2017/03/01 | English | 130 |
| The role of blood rheology in sickle cell disease | 2016/03/01 | English | 129 |
| The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia | 2012/05/01 | English | 129 |
| Hyperleukocytosis, leukostasis and leukapheresis: Practice management | 2012/05/01 | English | 129 |
| The past and future of CD33 as therapeutic target in acute myeloid leukemia | 2014/07/01 | English | 127 |
| The gray platelet syndrome: Clinical spectrum of the disease | 2007/01/01 | English | 126 |
| Targeting MCL-1 in hematologic malignancies: Rationale and progress | 2020/11/01 | English | 125 |
| Thrombin generation: What have we learned? | 2012/09/01 | English | 125 |
| The role of vena caval filters in the management of venous thromboembolism | 2005/07/01 | English | 125 |